ReviewAnnals of translational medicine2026
Fertility preservation in young women with breast cancer: a narrative review of effectiveness, oncologic safety, and clinical practice implications.
Review in Annals of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Breast cancer is the most frequently diagnosed malignancy among women of reproductive age, and advances in cancer survival have increased the relevance of fertility preservation (FP) as a component of comprehensive oncologic care. Concerns regarding treatment-related gonadotoxicity, potential delays in chemotherapy initiation, and long-term oncologic safety continue to influence clinical decision-making. This narrative review of systematic reviews aimed to synthesize contemporary evidence on FP methods in young women with breast cancer, focusing on effectiveness, timing, and oncologic safety. Methods: A structured narrative review of systematic reviews and meta-analyses was conducted using PubMed/MEDLINE and Web of Science from database inception through December 2025. Eligible articles were English-language systematic reviews evaluating FP strategies in premenopausal or perimenopausal women with breast cancer and reporting reproductive and/or oncologic outcomes. Data were extracted using a predefined framework, and findings were integrated through qualitative synthesis. Key Content and Findings: Sixteen systematic reviews were included. FP strategies evaluated included temporary ovarian suppression with gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy, controlled ovarian stimulation (COS) with oocyte or embryo cryopreservation, and alternative approaches such as ovarian tissue cryopreservation (OTC) and in vitro maturation (IVM). COS followed by embryo cryopreservation demonstrated the highest rates of clinical pregnancy and live birth. GnRHa use was consistently associated with improved ovarian function recovery, reduced premature ovarian insufficiency, and increased post-treatment pregnancy rates. Across studies, FP interventions were not associated with increased risks of disease recurrence or compromised survival outcomes. Conclusions: Current evidence supports the effectiveness and oncologic safety of established FP preservation strategies in young women with breast cancer. Importantly, the integration of structured oncofertility pathways into routine oncology practice requires early referral systems, multidisciplinary coordination, and individualized risk assessment. Translating these findings into practice is essential to ensure equitable access to FP within comprehensive cancer care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.